Table 4.
Seven samples (six patients) with discordant results between the different methods
| Patient | Microscopy | Parasitaemia by microscopy | 18S PCR assays | Mitochondrial PCR/sequencing | Primary/recurrent infection | Place of infection | Interpretation |
|---|---|---|---|---|---|---|---|
|
P 1 |
Negative |
01 |
Pm |
Pm |
Primary |
Ghana |
Pm overlooked by microscopy |
|
P 2 |
Negative2 |
01 |
Pv |
Pv |
Primary |
New Guinea |
Pv overlooked by microscopy |
|
P 2 |
Pf, Pv or Pk |
1% |
Pv |
Pv |
Recurrent (Relapse) |
New Guinea |
Inconclusive/ incorrect diagnosis by microscopy |
|
P 3 |
Pf + Po |
<1% |
Po |
Po |
Recurrent (Relapse) |
Uganda |
Over-diagnosed mixed infection by microscopy |
|
P 4 |
Pf |
<1% |
Pf + Pm |
Pf |
Primary |
Liberia |
Under-diagnosed mixed infection by microscopy/sequencing |
|
P 5 |
Pf + Pv |
1% |
Pv |
Pv |
Primary3 |
SEA or CA |
Over-diagnosed mixed infection by microscopy |
| P 6 | Pf 4 | <1% | Negative | Pf | Recurrent (Recrudescence) | Guinea | Un-detected low Pf parasitaemia by 18S PCR |
Abbreviations: Pf, Plasmodium falciparum; Pv, Plasmodium vivax; Po, Plasmodium ovale; Pm, Plasmodium malariae; Pk, Plasmodium knowlesi; SEA, South east Asia; CA, Central America.
1 Not detected any parasites.
2 Positive microscopy two days later (1% parasitaemia) and then the patient was diagnosed with severe malaria and treatment initiated.
3 Not given hypnozoite-eradicating treatment and re-admitted four weeks later with relapse of Plasmodium vivax.
4 Only one parasite detected.